Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/R014949/1)
Wellcome Trust (215574/Z/19/Z)
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 1 October 2026
First Online: 7 October 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Competing interests: J.P.M. is CSO of YouthBio Therapeutics, an advisor/consultant for ElixIRA Pharma, AND Biotech AG, and NOVOS, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science.
